Intrinsic Value of S&P & Nasdaq Contact Us

Artivion, Inc. AORT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
$123.97
+226.7%
Analyst Price Target
$52.00
+37%

Artivion, Inc. (AORT) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 10 Buy, 2 Hold.

The consensus price target is $52.00 (low: $50.00, high: $55.00), representing an upside of 37% from the current price $37.95.

Analysts estimate Earnings Per Share (EPS) of $0.01 and revenue of $0.39B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.32 vs est $0.01 (missed -3940.2%). 2025: actual $0.22 vs est $0.21 (beat +2.8%). Analyst accuracy: 47%.

AORT Stock — 12-Month Price Forecast

$52.00
▲ +37.02% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Artivion, Inc., the average price target is $52.00, with a high forecast of $55.00, and a low forecast of $50.00.
The average price target represents a +37.02% change from the last price of $37.95.
Highest Price Target
$55.00
Average Price Target
$52.00
Lowest Price Target
$50.00

AORT Analyst Ratings

Buy
12
Ratings
10 Buy
2 Hold
Based on 12 analysts giving stock ratings to Artivion, Inc. in the past 3 months
Rating breakdown
Buy
10 83%
Hold
2 17%
83%
Buy
10 analysts
17%
Hold
2 analysts
0%
Sell
0 analysts

EPS Estimates — AORT

47%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.32 vs Est $0.01 ▼ 102.6% off
2025 Actual $0.22 vs Est $0.21 ▲ 2.7% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — AORT

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.389B vs Est $0.392B ▼ 0.9% off
2025 Actual $0.441B vs Est $0.442B ▼ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message